you are here: Home News Johnson And Johnson

Johnson And Johnson

‘Not able to sell, what next’: Chemist body asks Johnson and Johnson as FDA orders withdrawal of baby powder from market
'Withdraw baby powder from the market': Maharashtra FDA tells J&J
J&J’s move to exit talc globally need not raise any fresh concerns
Dear Johnson & Johnson, are babies in India of a lesser god?
Johnson & Johnson won’t take controversial baby powder off shelves in India
60 million COVID doses gone waste in US: A blot on pharma industry
New analyses show Johnson & Johnson’s one-dose vaccine works well
Delhi HC stays order asking J&J to deposit over Rs 230cr profit from sale of baby products
Delhi HC stays penalty notice on Johnson and Johnson for 'profiteering' on sale of sanitary napkins
Pharma wrap: J&J in news again Australian court rules against company over pelvic mesh lawsuit
Delhi HC asks J&J to pay Rs 25 Lakh to 67 patients who had revision surgery for faulty hip implants
SC closes case against Johnson & Johnson for faulty hip implants
J&J faulty implant victims allege lack of transparency in deciding compensation, threaten boycott
Medical experts seek formation of a national joint replacement registry
J&J case: Govt asks 'victims' to approach central or state panel
Johnson & Johnson suppressed key facts of the faulty hip replacements sold in India: Report
J&J plans to expand tuberculosis R&D in India
J&J working with Indian govt on tuberculosis treatment
States begin testing J&J baby products for cancer-causing agents
Strides Shasun gets CCI nod to buy 7 brands of J&J
Dishman gets licence from J&J to make TB drug raw material
Sun Pharma dips 2% as J&J signs agreement to produce Doxil
Sun Pharma hits record high, CLSA says buy post Doxil issue
Sun Pharma may get windfall gains on cancer drug Doxil
J&J to resume ops at Mulund plant after HC reprieve

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Johnson And Johnson

‘Not able to sell, what next’: Chemist body asks Johnson and Johnson as FDA orders withdrawal of baby powder from market

'Withdraw baby powder from the market': Maharashtra FDA tells J&J

J&J’s move to exit talc globally need not raise any fresh concerns

Dear Johnson & Johnson, are babies in India of a lesser god?

Johnson & Johnson won’t take controversial baby powder off shelves in India

60 million COVID doses gone waste in US: A blot on pharma industry

New analyses show Johnson & Johnson’s one-dose vaccine works well

Delhi HC stays order asking J&J to deposit over Rs 230cr profit from sale of baby products

Delhi HC stays penalty notice on Johnson and Johnson for 'profiteering' on sale of sanitary napkins

Pharma wrap: J&J in news again Australian court rules against company over pelvic mesh lawsuit

Delhi HC asks J&J to pay Rs 25 Lakh to 67 patients who had revision surgery for faulty hip implants

SC closes case against Johnson & Johnson for faulty hip implants

J&J faulty implant victims allege lack of transparency in deciding compensation, threaten boycott

Medical experts seek formation of a national joint replacement registry

J&J case: Govt asks 'victims' to approach central or state panel

Johnson & Johnson suppressed key facts of the faulty hip replacements sold in India: Report

J&J plans to expand tuberculosis R&D in India

J&J working with Indian govt on tuberculosis treatment

States begin testing J&J baby products for cancer-causing agents

Strides Shasun gets CCI nod to buy 7 brands of J&J

Dishman gets licence from J&J to make TB drug raw material

Sun Pharma dips 2% as J&J signs agreement to produce Doxil

Sun Pharma hits record high, CLSA says buy post Doxil issue

Sun Pharma may get windfall gains on cancer drug Doxil

J&J to resume ops at Mulund plant after HC reprieve